Results from a prospective, multicentre, clinical trial published today in the peer-reviewed British Journal of Dermatology link to article showed that AI helps significantly improve melanoma detection rates. The trial, conducted in 37 Swedish primary care facilities was designed to evaluate Dermalyser a smartphone-based diagnostic decision support system empowered by advanced artificial intelligence (AI). 228 patients examined in primary care and exhibiting skin lesions raising concern for melanomas by the doctor, also underwent an additional assessment using a...